New York State Common Retirement Fund
KNSA icon

New York State Common Retirement Fund’s Kiniksa Pharmaceuticals KNSA Stock Holding History

New York State Common Retirement Fund’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4M Buy
272,579
+62,962
+30% +$3.27M 0.02% 530
2026
Q1 		$10.1M Buy
+209,617
New +$9.29M 0.01% 718
2025
Q3 		– Sell
-514
Closed -$14.2K – 3211
2025
Q2 		$14.2K Sell
514
-14,734
-97% -$375K ﹤0.01% 3140
2025
Q1 		$339K Hold
15,248
– – ﹤0.01% 2021
2024
Q4 		$302K Buy
15,248
+1,680
+12% +$38.3K ﹤0.01% 2121
2024
Q3 		$339K Buy
13,568
+1,400
+12% +$34.1K ﹤0.01% 2089
2024
Q2 		$227K Sell
12,168
-27,603
-69% -$517K ﹤0.01% 2369
2024
Q1 		$785K Buy
39,771
+4,904
+14% +$95.8K ﹤0.01% 1897
2023
Q4 		$612K Buy
34,867
+20,841
+149% +$343K ﹤0.01% 2015
2023
Q3 		$244K Buy
14,026
+98
+0.7% +$1.65K ﹤0.01% 2341
2023
Q2 		$196K Sell
13,928
-46
-0.3% -$616 ﹤0.01% 2506
2023
Q1 		$150K Sell
13,974
-7,900
-36% -$104K ﹤0.01% 2708
2022
Q4 		$328K Sell
21,874
-10
-0% -$146 ﹤0.01% 2520
2022
Q3 		$281K Buy
21,884
+5,486
+33% +$62.5K ﹤0.01% 2630
2022
Q2 		$159K Sell
16,398
-26,696
-62% -$249K ﹤0.01% 2889
2022
Q1 		$428K Buy
43,094
+8,817
+26% +$93.4K ﹤0.01% 2471
2021
Q4 		$403K Buy
34,277
+15,143
+79% +$186K ﹤0.01% 2546
2021
Q3 		$218K Sell
19,134
-5,388
-22% -$70.2K ﹤0.01% 2877
2021
Q2 		$342K Buy
24,522
+222
+0.9% +$3.37K ﹤0.01% 2791
2021
Q1 		$450K Hold
24,300
– – ﹤0.01% 2504
2020
Q4 		$429K Buy
24,300
+6,700
+38% +$118K ﹤0.01% 2427
2020
Q3 		$270K Hold
17,600
– – ﹤0.01% 2521
2020
Q2 		$448K Buy
17,600
+4,000
+29% +$83.6K ﹤0.01% 2275
2020
Q1 		$211K Hold
13,600
– – ﹤0.01% 2434
2019
Q4 		$150K Hold
13,600
– – ﹤0.01% 2864
2019
Q3 		$116K Hold
13,600
– – ﹤0.01% 2987
2019
Q2 		$184K Buy
13,600
+9,800
+258% +$152K ﹤0.01% 2862
2019
Q1 		$69K Hold
3,800
– – ﹤0.01% 3025
2018
Q4 		$107K Buy
+3,800
New +$79.3K ﹤0.01% 2944

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

New York State Common Retirement Fund's KNSA Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Kiniksa Pharmaceuticals (KNSA) stake by 30% in Q2 2026, buying an estimated $3.27M and bringing the position to 272,579 shares worth $17.4M. The position accounts for 0.02% of the portfolio, ranked #530.

New York State Common Retirement Fund first reported a position in KNSA in Q4 2018 and has held it in 29 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • New York State Common Retirement Fund held 272,579 shares of Kiniksa Pharmaceuticals worth $17.4M as of Q2 2026.
  • New York State Common Retirement Fund bought 62,962 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $3.27M.
  • Kiniksa Pharmaceuticals made up 0.02% of New York State Common Retirement Fund's portfolio in Q2 2026, its #530 holding.
  • New York State Common Retirement Fund first reported a position in Kiniksa Pharmaceuticals in Q4 2018 and has held it in 29 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.